Home > Insider Trading > Baxalta Inc > Profile

Baxalta Inc (BXLT)

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Investors' Holdings
News

Get Email Alerts

Related Insiders

Brian Goff, Evp And President, Hematology, 2016-06-07
J. Robert Hombach, Evp. Cfo And Coo, 2016-06-07
John Glasspool, See Remarks, 2016-06-07

Brian Goff, Evp And President, Hematology, 2016-06-07
J. Robert Hombach, Evp. Cfo And Coo, 2016-06-07
John Glasspool, See Remarks, 2016-06-07
Jacopo Leonardi, Evp And President, Immunology, 2016-06-07
L P Albert Stroucken, Director, 2016-06-07
Dagmar Rosa-Bjorkeson, Evp And President, Biosimilars, 2016-06-07
G Peter Edwards, Svp And General Counsel, 2016-06-07
D Gail Fosler, Director, 2016-06-07
J John Orloff, See Remarks, 2016-06-07
D John Forsyth, Director, 2016-06-07
D. David Meek, Evp And President, Oncology, 2016-06-07
Ludwig Hantson, President And Ceo, 2016-06-07
T Wayne Hockmeyer, Director, 2016-06-07
Anne-Marie Law, Evp & Head Of Human Resources, 2016-06-07
Patrice Zagame, See Remarks, 2016-06-07
Iii R James Gavin, Director, 2016-06-07
Francois Nader, Director, 2016-06-07
A. John Mccoy, Svp And Controller, 2016-06-07
Jean Karen Ferrante, Director, 2016-06-07
E Blake Devitt, Director, 2016-06-07
Baxter International Inc, Large Shareholder, 2016-03-23
P. David Scharf, See Remarks, 2015-06-09

Show All Insiders (22)

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2017, 3:56 pm based on SEC 13F filings Last update: November 14, 2017, 3:56 pm

No.	Hedge Fund	Value (x$1000)	% Port
1.	GLG Partners Noam Gottesman	$0	0%
2.	Highbridge Capital ManagementCALL Glenn Russell Dubin	$0	0%
3.	Highbridge Capital Management Glenn Russell Dubin	$0	0%
4.	Paulson & Co John Paulson	$0	0%
5.	Perella Weinberg Partners Daniel Arbess	$0	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Devitt	$0.00	387	Director	32,857	2016-05-24	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Forsyth	$39.97	5,660	Director	23,324	2016-03-24	Filing
Stroucken	$39.98	5,660	Director	20,755	2016-03-24	Filing
Gavin	$39.97	5,660	Director	26,343	2016-03-24	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value (x$1000)	% Port
1.	Morgan Dempsey Capital Management Llc	0	$0	0%

News See All

Billionaire Daniel Och’s Favorite Stock Picks To Steer Out of Muddy Waters

Daniel S. Och's publicly-traded $61 billion hedge fund firm, Och-Ziff Capital Management, has been in choppy waters since last year's summer and even trampled on investors' dividend hopes for the first...... (read more)

June 8th, 2016 - Hedge Funds News - Comments

Five Stocks Capturing a Lot of Attention from Hedge Funds

While the likes of Allergan plc Ordinary Shares (NYSE:AGN) and Alphabet Inc (NASDAQ:GOOGL), constantly make the headlines and especially after the release of the hedge funds' 13F filing, some stocks...... (read more)

May 25th, 2016 - Hedge Fund Analysis Hedge Funds News - Comments

Swedish-Born Tom Sandell Focuses on Equity Special Events Opportunities

Sandell Asset Management Corporation is a New York-based alternative asset management firm that predominantly focuses on equity special events and credit opportunities. The asset manager, founded by Thomas...... (read more)

May 19th, 2016 - Hedge Fund Analysis Hedge Funds News - Comments

Billionaires Paulson, Cohen, Soros and Others Added These Major Stocks to Their Portfolios in Q1

Although many investors and analysts have voiced their discontent with the herd-like behavior and weak performance of the hedge fund industry of late, there are some hedge fund managers who have successfully...... (read more)

May 18th, 2016 - Gold Hedge Fund Analysis Hedge Funds News - Comments

Mariner Investment’s Top Healthcare Picks

Among some 800 hedge funds we track at Insider Monkey, we seldom come across funds that specialize in investing in a particular sector or have a penchant for investing in companies that trade above or...... (read more)

May 16th, 2016 - Hedge Funds News - Comments

Why Baxalta Inc (BXLT) Is A Sell Now For Dividend Growth Investors

“Baxalta’s high expected total returns and competitive advantage should give the company a P/E ratio above the S&P 500’s. Fortunately for shareholders, Baxalta’s P/E ratio is still low at...... (read more)

January 19th, 2016 - Dividend Stocks News Stock Analysis - Comments

Why These 4 Stocks are Among the Most Actively Traded Today

The U.S stock market is trading slightly in green territory despite declining oil prices caused by fears about the state of China's economy. Amid this backdrop, shares of Baxalta Inc (NYSE:BXLT), Shire...... (read more)

January 11th, 2016 - Market Movers News - Comments

Do Hedge Funds Love Baxalta Inc (BXLT)?

It's a little-known fact that stock performance is not evenly distributed (i.e. you don't have a 50/50 chance of picking a market-beating stock). In fact, despite the S&P 500 gaining about 5.2% between...... (read more)

November 27th, 2015 - Hedge Funds News - Comments

Hedge Funds Like Ariad Pharmaceuticals, Inc. (ARIA) Despite the Failed Deal

Less than a week after reports that Baxalta Inc (NYSE:BXLT) wanted to acquire Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), the discussions of a deal, might be over, although none of the two reports...... (read more)

September 3rd, 2015 - Hedge Funds News - Comments

Undervalued Baxalta Inc (BXLT) Shares Target of Acquisition by Shire PLC (ADR) (SHPG)

Baxalta Inc (NYSE:BXLT) was recently spun-off from Baxter International Inc (NYSE:BAX) on July 1st, 2015. The company has 16,000 employees and around $6 billion in expected revenues. Hedge funds are...... (read more)

August 6th, 2015 - Dividend Stocks News Stock Analysis - Comments

Click here to See All News